175 related articles for article (PubMed ID: 21415071)
1. Prognostic value of mid-regional pro-adrenomedullin in patients with heart failure after an acute myocardial infarction.
Klip IT; Voors AA; Anker SD; Hillege HL; Struck J; Squire I; van Veldhuisen DJ; Dickstein K;
Heart; 2011 Jun; 97(11):892-8. PubMed ID: 21415071
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
Khan SQ; O'Brien RJ; Struck J; Quinn P; Morgenthaler N; Squire I; Davies J; Bergmann A; Ng LL
J Am Coll Cardiol; 2007 Apr; 49(14):1525-32. PubMed ID: 17418290
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.
Gegenhuber A; Struck J; Dieplinger B; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
J Card Fail; 2007 Feb; 13(1):42-9. PubMed ID: 17339002
[TBL] [Abstract][Full Text] [Related]
4. Comparison of long-term prognostic value of N-terminal-proBNP and midregional-pro-adrenomedullin in patients with acute myocardial infarction.
Walter T; Brueckmann M; Lang S; Sauer T; Fiedler E; Papassotiriou J; Behnes M; Elmas E; Borggrefe M; Bertsch T
Clin Lab; 2010; 56(7-8):303-9. PubMed ID: 20857894
[TBL] [Abstract][Full Text] [Related]
5. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study.
Voors AA; von Haehling S; Anker SD; Hillege HL; Struck J; Hartmann O; Bergmann A; Squire I; van Veldhuisen DJ; Dickstein K;
Eur Heart J; 2009 May; 30(10):1187-94. PubMed ID: 19346228
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of mid-regional pro-adrenomedullin levels taken on admission and discharge in non-ST-elevation myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) II study.
Dhillon OS; Khan SQ; Narayan HK; Ng KH; Struck J; Quinn PA; Morgenthaler NG; Squire IB; Davies JE; Bergmann A; Ng LL
J Am Coll Cardiol; 2010 Jul; 56(2):125-33. PubMed ID: 20620726
[TBL] [Abstract][Full Text] [Related]
7. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
[TBL] [Abstract][Full Text] [Related]
8. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
Maisel A; Mueller C; Nowak R; Peacock WF; Landsberg JW; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng L; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Terracciano G; Kremastinos D; Hartmann O; von Haehling S; Bergmann A; Morgenthaler NG; Anker SD
J Am Coll Cardiol; 2010 May; 55(19):2062-76. PubMed ID: 20447528
[TBL] [Abstract][Full Text] [Related]
9. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
[TBL] [Abstract][Full Text] [Related]
10. Comparison of N-terminal pro-brain natriuretic peptide versus electrophysiologic study for predicting future outcomes in patients with an implantable cardioverter defibrillator after myocardial infarction.
Yu H; Oswald H; Gardiwal A; Lissel C; Klein G
Am J Cardiol; 2007 Aug; 100(4):635-9. PubMed ID: 17697820
[TBL] [Abstract][Full Text] [Related]
11. High levels of N-terminal pro B-type natriuretic peptide are associated with ST resolution failure after reperfusion for acute myocardial infarction.
Lorgis L; Zeller M; Dentan G; Sicard P; Jolak M; L'Huillier I; Vincent-Martin M; Beer JC; Makki H; Gambert P; Cottin Y;
QJM; 2007 Apr; 100(4):211-6. PubMed ID: 17434911
[TBL] [Abstract][Full Text] [Related]
12. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
13. Plasma N-terminal pro-B-type natriuretic peptide for prediction of death or nonfatal myocardial infarction following percutaneous coronary intervention.
de Winter RJ; Stroobants A; Koch KT; Bax M; Schotborgh CE; Mulder KJ; Sanders GT; van Straalen JP; Fischer J; Tijssen JG; Piek JJ
Am J Cardiol; 2004 Dec; 94(12):1481-5. PubMed ID: 15589000
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of the N-terminal pro-B-type natriuretic peptide in the elderly with acute myocardial infarction.
Drewniak W; Snopek G; Zarukiewicz M; Borys M; Dabrowski M
Kardiol Pol; 2008 Jul; 66(7):750-5; discussion 756-7. PubMed ID: 18690566
[TBL] [Abstract][Full Text] [Related]
15. Plasma natriuretic peptides up to 2 years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy.
Squire IB; Ørn S; Ng LL; Manhenke C; Shipley L; Aarsland T; Dickstein K
J Card Fail; 2005 Sep; 11(7):492-7. PubMed ID: 16198243
[TBL] [Abstract][Full Text] [Related]
16. Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery.
Goei D; Schouten O; Boersma E; Welten GM; Dunkelgrun M; Lindemans J; van Gestel YR; Hoeks SE; Bax JJ; Poldermans D
Am J Cardiol; 2008 Jan; 101(1):122-6. PubMed ID: 18157978
[TBL] [Abstract][Full Text] [Related]
17. Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome.
Kubler P; Jankowska EA; Majda J; Reczuch K; Banasiak W; Ponikowski P
Int J Cardiol; 2008 Oct; 129(3):373-8. PubMed ID: 18054808
[TBL] [Abstract][Full Text] [Related]
18. Changes in the Doppler myocardial performance index during dobutamine echocardiography: association with neurohormonal activation and prognosis after acute myocardial infarction.
Nørager B; Husic M; Møller JE; Bo Hansen A; Pellikka PA; Egstrup K
Heart; 2006 Aug; 92(8):1071-6. PubMed ID: 16387817
[TBL] [Abstract][Full Text] [Related]
19. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
Latini R; Maggioni AP; Peri G; Gonzini L; Lucci D; Mocarelli P; Vago L; Pasqualini F; Signorini S; Soldateschi D; Tarli L; Schweiger C; Fresco C; Cecere R; Tognoni G; Mantovani A;
Circulation; 2004 Oct; 110(16):2349-54. PubMed ID: 15477419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]